As of 2017 over 60 peptide drugs have been approved in the US, Europe and Japan.
The Sejer Pederson group at Novo Nordisk realise the importance of greening the synthesis of peptide therapeutics within industry, and identify methods on how we can achieve this.
Find out more in the Open Access article:
“Greening the synthesis of peptide therapeutics: an industrial perspective”
Vincent Martin et al. RSC Advances, 2020, 10, 42457-42492 DOI:10.1039/D0RA07204D
Tweet about it here!
